An Economic Overview of Chronic Obstructive Pulmonary Disease

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.6, 2001-06, pp. : 623-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The economic impact of chronic obstructive pulmonary disease

By Hilleman Daniel E Faulkner Michele A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 219-228

Informa Healthcare

Access to resources Recommend Favorite

Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options

By Friedman M.

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 245-254

Adis International

Access to resources Recommend Favorite

A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease

By Menn Petra Leidl Reiner Holle Rolf

PharmacoEconomics, Vol. 30, Iss. 9, 2012-09 ,pp. : 825-840

Adis International

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite